XML 43 R31.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' Equity (Tables)
6 Months Ended
Jun. 30, 2018
Equity [Abstract]  
Schedule of Number of Shares of Common Stock Reserved for Future Issuance

The Company has reserved for future issuance the following number of shares of common stock:

 

 

 

June 30,

2018

 

 

December 31, 2017

 

Unvested restricted stock

 

 

956,247

 

 

 

1,164,040

 

Common stock options

 

 

385,974

 

 

 

666,717

 

Shares available for issuance under the 2013 Stock Option and

   Incentive Plan

 

 

4,618,038

 

 

 

3,273,334

 

Shares available for issuance under the 2013 Employee Stock

   Purchase Plan

 

 

788,503

 

 

 

788,503

 

 

 

 

6,748,762

 

 

 

5,892,594

 

 

Summary of Roll Forward of Restricted Stock Activity Pursuant to the 2010 and 2013 Stock Plan

The following table shows a roll forward of restricted stock activity pursuant to the 2010 Stock Plan and the 2013 Stock Plan:

 

 

 

Number of

Shares

 

Unvested at December 31, 2017

 

 

1,164,040

 

Granted

 

 

296,005

 

Vested

 

 

(332,586

)

Forfeited

 

 

(171,212

)

Unvested at June 30, 2018

 

 

956,247

 

 

Summary of Stock Option Activity Under the 2010 Stock Plan and the 2013 Stock Plan

A summary of stock option activity under the 2010 Stock Plan and the 2013 Stock Plan for the six months ended June 30, 2018 is as follows:

 

 

 

Number of

Shares

 

 

Weighted-

Average

Exercise

Price

 

 

Weighted-

Average

Remaining

Contractual

Term

(In Years)

 

 

Aggregate

Intrinsic

Value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(in thousands)

 

Outstanding as of December 31, 2017

 

 

666,717

 

 

$

19.53

 

 

 

5.6

 

 

$

32,450

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(272,917

)

 

 

19.48

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(7,826

)

 

 

34.10

 

 

 

 

 

 

 

 

 

Outstanding as of June 30, 2018

 

 

385,974

 

 

$

19.27

 

 

 

5.3

 

 

$

45,325

 

Exercisable as of June 30, 2018

 

 

360,495

 

 

$

18.40

 

 

 

5.1

 

 

$

42,646

 

 

Recorded Stock-Based Compensation Expense in the Consolidated Statements of Operations and Comprehensive Loss

The Company recorded stock-based compensation expense in the statements of operations and comprehensive loss as follows (in thousands):

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2018

 

 

2017

 

 

2018

 

 

2017

 

Cost of revenue

 

$

309

 

 

$

563

 

 

$

547

 

 

$

1,658

 

Selling and marketing

 

 

957

 

 

 

1,297

 

 

 

1,869

 

 

 

2,517

 

General and administrative

 

 

1,813

 

 

 

3,159

 

 

 

3,094

 

 

 

5,937

 

Research and development

 

 

1,006

 

 

 

1,707

 

 

 

1,783

 

 

 

3,013

 

Total

 

$

4,085

 

 

$

6,726

 

 

$

7,293

 

 

$

13,125